INSP
Inspire Medical Systems, Inc.
Healthcare · Medical - Devices
Undervalued·Quality 100·RSI 43·DCF +166%·Conviction 80
Investment Thesis — Inspire Medical Systems, Inc.
The market is mispricing Inspire Medical Systems by fixating on recent growth deceleration and macro headwinds, overlooking the long-term structural demand for its differentiated sleep apnea solution. This creates an opportunity to acquire a high-growth medical device innovator at a valuation typically reserved for mature, slower-growing companies.
Catalysts
- Strong beat on quarterly patient implant growth, signaling re-acceleration
- Expanded insurance coverage or favorable reimbursement policy updates
- Positive long-term clinical outcomes data reinforcing device efficacy and safety
Risk Factors
- Emergence of a highly effective, less invasive competitive OSA treatment
- Sustained slowdown in new physician training and patient referrals
- Adverse regulatory action or significant product recall impacting trust
Key Debates
Revenue reaccelerates to 15%+ by Q4, justifying 30x P/E
INSP's 29.76x P/E contracts to 20x by Q4
INSP rebounds 20% by Q3 on extreme oversold conditions